Los Angeles Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.7M | Buy |
|
|||||
|
2025
Q2 | $22M | Sell |
|
|||||
|
2025
Q1 | $21.8M | Sell |
|
|||||
|
2024
Q4 | $22.3M | Sell |
|
|||||
|
2024
Q3 | $37.7M | Buy |
|
|||||
|
2024
Q2 | $289K | Sell |
|
|||||
|
2024
Q1 | $442K | Sell |
|
|||||
|
2023
Q4 | $3.26M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $286K | Hold |
|
|||||
|
2023
Q1 | $302K | Sell |
|
|||||
|
2022
Q4 | $491K | Sell |
|
|||||
|
2022
Q3 | $1.22M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $328K | Sell |
|
|||||
|
2019
Q2 | $372K | Sell |
|
|||||
|
2019
Q1 | $4.62M | Sell |
|
|||||
|
2018
Q4 | $3.63M | Sell |
|
|||||
|
2018
Q3 | $12.9M | Sell |
|
|||||
|
2018
Q2 | $29.8M | Buy |
|
|||||
|
2018
Q1 | $8.33M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $10.9M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.25M | Sell |
|
|||||
|
2015
Q3 | $1.23M | Sell |
|
|||||
|
2015
Q2 | $2.54M | Sell |
|
|||||
|
2015
Q1 | $17M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.13M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $253K | Buy |
|